Coherus Oncology, Inc.

CHRS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$125,987$102,891$63,547$417,195
Short-Term Investments$0$14,857$128,134$0
Receivables$122,334$260,522$109,964$123,022
Inventory$70,094$62,605$38,791$37,642
Other Curr. Assets$23,168$34,756$40,798$24,464
Total Curr. Assets$341,583$475,631$381,234$602,323
Property Plant & Equip (Net)$2,837$5,119$8,754$7,813
Goodwill$0$943$943$943
Intangibles$53,646$70,730$4,988$2,620
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$50,467$77,181$84,928$65,635
Total NC Assets$106,950$153,973$99,613$77,011
Other Assets$0$0$0$0
Total Assets$448,533$629,604$480,847$679,334
Liabilities
Payables$28,456$35,219$11,526$16,159
Short-Term Debt$1,691$2,145$4,318$3,492
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$252,834$294,407$122,850$145,676
Total Curr. Liab.$282,981$331,771$138,694$165,327
LT Debt$268,213$478,697$476,104$415,531
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$1,102$1,102$0$0
Other NC Liab.$28,227$11,459$3,467$750
Total NC Liab.$297,542$491,258$479,571$416,281
Other Liabilities$0$0$0$0
Cap. Leases$4,977$7,473$9,364$10,743
Total Liabilities$580,523$823,029$618,265$581,608
Equity
Pref Stock$0$0$0$0
Common Stock$12$11$8$7
Retained Earnings-$1,550,993-$1,579,500-$1,341,608-$1,049,854
AOCI-$275-$248-$249-$270
Other Equity$1,419,266$1,386,312$1,204,431$1,147,843
Total Equity-$131,990-$193,425-$137,418$97,726
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$448,533$629,604$480,847$679,334
Net Debt$143,917$377,951$416,875$1,828